drugset / Trial / NCT04106258

A Pilot Study of Hemoporfin PDT in Children(2-7 Years Old) With Port-wine Stain

NCT04106258 ↗

Non-randomizedSequentialSingle-blindTreatment

Summary

This pilot study aims to evaluate the safety and efficacy of hemoporfin photodynamic therapy (PDT) with different light doses for port-wine stain (PWS)in 2-7 years old children. The pharmacokinetic behavior and pharmacokinetic parameters of hemoporfin in children will be investigated as well.

Timeline

Start
2020-05-27
Primary completion
2023-02-15
Completion
2023-02-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Hematoporphyrin Small molecule 5 mg/kg Intravenous

Indications

No indication recorded.